Alpha 2.0
Login Register
» Articles » PMID: 29790897

Six Cycles of R-CHOP-21 Are Not Inferior to Eight Cycles for Treatment of Diffuse Large B-cell Lymphoma: a Nordic Lymphoma Group Population-based Study

Overview
Journal Ann Oncol
Publisher Elsevier
Specialty Oncology
Date 2018 May 24
PMID 29790897
Citations 8
Authors
T Wasterlid
J L Biccler
P N Brown
M Bogsted
G Enblad
J Meszaros Jorgensen
J H Christensen
B E Wahlin
K E Smedby
T C El-Galaly
M Jerkeman
Affiliations
Soon will be listed here.
Citing Articles

Unusual symptoms reveal a rare splenic lymphoma: a case report of PS-DLBCL with neck and shoulder pain as the initial presentation.

Hu S, Hao Y, Liu X, Liu H Front Oncol. 2025; 15:1449966.

PMID: 39968068 PMC: 11832353. DOI: 10.3389/fonc.2025.1449966.

Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma.

Maas C, van Klaveren D, Durmaz M, Visser O, Issa D, Posthuma E Blood Cancer J. 2024; 14(1):157.

PMID: 39266543 PMC: 11393348. DOI: 10.1038/s41408-024-01137-0.

[Chinese expert consensus on the diagnosis and management of elderly patients with diffuse large B-cell lymphoma (2024)].

Zhonghua Xue Ye Xue Za Zhi. 2024; 45(4):322-329.

PMID: 38951058 PMC: 11168000. DOI: 10.3760/cma.j.cn121090-20231228-00343.

The Relative Dose Intensity Changes during Cycles of Standard Regimens in Patients with Diffuse Large B-Cell Lymphoma.

Lee S, Fujita K, Morishita T, Negoro E, Tsukasaki H, Oiwa K Cancers (Basel). 2023; 15(18).

PMID: 37760427 PMC: 10526837. DOI: 10.3390/cancers15184458.

Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options.

Vodicka P, Klener P, Trneny M Onco Targets Ther. 2022; 15:1481-1501.

PMID: 36510607 PMC: 9739046. DOI: 10.2147/OTT.S326632.